[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-DBVT":3,"homepage-market-summary":30,"stock-news-DBVT":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"DBVT","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"DBV Technologies S.A. American Depositary Shares","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.","170","Chatillon, I0",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":19,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},10.55,10.92,11.01,10.47,11.21,-0.66,-5.89,672939.551647,4055,10.7646,26.185,323320.847490092,0.5,3004,{"status":31,"indices":32,"watchlist":76,"sectors":98,"benchmarks":154},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":39,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":39,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":39,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":39},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":39},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":39},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":39},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":39},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":89,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},8,[175,181,187,193,199,205,211,216],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years - markets.businessinsider.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogJBVV95cUxOYW9HU21sTko2T0RMMmdIaFY2YzF5U1VyNFFVcloxYkNmSEVGLV9vS3ZIQl9kSFprb3g0MlJsc2ltbklPbG1BaDhqVXRjbU91eG9QamVGYXA1dDZsX3QyQ3RjMGpFc0dTMjB6OXllRDh2WU5SQ0oxbU9WN1BsMElHdlppYTVXY3g0V1ZPNV95RkhLUFE2djB3al8tbUdhRm9IRlRUSGd2YTJka3FrS3dXRlB1MGZvOWFUOUs4N2JzX2RQdDFKSXN0ZGRZU0hyQW1hSHpOUlVqZWVqVU5mYUdGR3o0SUt5UmRwTVM0VFdIQmx2cG9xR01hQVdESjRjTjI2d2k4U2NVQ2VnRmxZNVp1R3JnUkRrVDZibGpjQXJCWEt6Zw?oc=5","Tue, 29 Sep 2026 23:02:52 GMT","DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years markets.businessinsider.com","markets.businessinsider.com",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Trading Systems Reacting to (DBVT) Volatility - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxObHNDa1oyS0hmVkNDdW5ma3A3M0xFX1lNMGk0ME1ja3FfOVRLWnNpbVFkM3ZDMlhmaFN6Zzh0c3dmZUFpNnE0QkpJbVFGN2JUeU1kS3pGdGs1ZUpvYUp6RW1oeXFYQW4wQWN0RDk0bUttcDl2Rm1DanBtcmFwWTdtc2hfTl9sSkR5N0ZEUHVyV3oxeEV2ckVuRXBMS1NkRUE4ZzhzcXZFUVVjM2ZrTlotTDBXRnZielZiQzhSNENZRQ?oc=5","Sun, 27 Sep 2026 14:48:02 GMT","Trading Systems Reacting to (DBVT) Volatility Stock Traders Daily","Stock Traders Daily",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and TransMedics Group (TMDX) - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMioAJBVV95cUxQcXp1MXNTR0x6Q1FrenBmaWZQRXMyWnIwTm0zNGhZVkt5RW1tdzRFaEJXZURJdlN0WEtkUjE1WFVMeWlyUi1KQUk5bVkyRXFLREVVZ0pWTHFMdElhM3NGbjVSeWgyaUpNLUdrWHJ3N1BvQjZIUlBqRXZIc3dRRjdDNzZadGUtZVZSeU9mcFVZYUdsV0g0RVN6Q2hDRzZRenBXcV9ybGxxUVRaQzVOOUZPWmZOZWpTRlJraTNkMDQzX1pGTlAxVldLbzZmMTh2ZXlKOXJObUo0WUZBb3lnLW85Z1BmVGFYdUFGZmdxZDBrYUZwYkRDdFR2Q0ZtNGlfSENUTWJwZGQxRWRPTnBDYU9Mb1FEMFRXN05lUlFELWcwSTY?oc=5","Wed, 23 Sep 2026 09:58:00 GMT","Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and TransMedics Group (TMDX) The Globe and Mail","The Globe and Mail",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"DBV Technologies Files FDA Biologics License Application for Via - gurufocus.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxQMndkdXhCV2VkWHBBd0E0dHhyVXl6U25LWGJHUF9ZVWxxMWNjc1hiczh0YkVvOGV6WjZqU3ZiX05QRl9BU0Vsd3dMcW9mNDRERWRnQTR6cUJnRW1iS0IyWlVYSDd4ZjZkSXdkQVZhS2l2aHZsdER3MUlMQ2pDVjE0V0hGX0xiVTBMVTdxZFhJeVAzejN4eEJyTkxabGdseWtCc052cXlPX01lTnZJT01SODhzTkxUa0VhVlBhTFJ2NUE3d2s?oc=5","Wed, 30 Sep 2026 05:36:52 GMT","DBV Technologies Files FDA Biologics License Application for Via gurufocus.com","gurufocus.com",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Citizens reiterates DBV Technologies stock rating on BLA milestone - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxNMElwRXdpZFNvUDJTbEx4VWhuM0E0N1VobGJ4WnlQU0phZXVzQWdUTTNienlMaFNFX1ZFUWlOeTdYZF9feVI3azVqcU04bVc1VWJ4Z0I0d1J5TlR3bmdHd0xzdkVoTUxER01MaWhwdkFoVXFMV3pEX3JyY2VxazFITzVCRUVfNjdlUmFNZnIzUkZxRmlfUlozY25iamNpT0NsNGF4TndEUkdia1FlNGM3WXFkaEtlQWJSSkYzU3JOSjdkNm55?oc=5","Wed, 30 Sep 2026 09:31:45 GMT","Citizens reiterates DBV Technologies stock rating on BLA milestone Investing.com","Investing.com",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"Why Is DBV Technologies (NASDAQ:DBVT) Suddenly a Must-Watch Healthcare Stocks Name? - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxPOS1oM2Q1T3o2dmR2dEtPRzAtdDFHNVJMMXFLMERMQzZvdUJpTzRROFBSUU1xLWRfTGhteHk2QmF6TWpGX0NIcHdHYU9wRkU5SzhWQ0kwb1ItSkxfWWtudTg3MDZESnZVeElOaDRITExKYm5IbnRGU0xiYnRiUUhhMDZkOXdNaFZRUDhtWjZ5Vng3QTBocVBPRlhlUHB5azB5ZldVbWNJeDlQZ2JhZ09mOTBmeldQaXlnVkljX0lBTC00dm8?oc=5","Wed, 30 Sep 2026 14:30:00 GMT","Why Is DBV Technologies (NASDAQ:DBVT) Suddenly a Must-Watch Healthcare Stocks Name? Kalkine Media","Kalkine Media",{"title":212,"link":213,"pubDate":214,"description":215,"source":210},"DBV Technologies Submits FDA Biologics License Application for VIASKIN Peanut Patch in Children Ages 4-7 - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5gFBVV95cUxQWm5hSEh4SFJiMWNndk5meHpGZC1qZmd4elpIcUJRSl8yRFpNWkI1YkVwRnZwT19BNVY2ZUZDbUoyNC03Z2I3RzlJTEdnd0NDdVZ5SER3aUk1em5tSU84eUZFczVZQTdacFhDdURObm02cHI0ci1pRmhtTi0ybWNiMExDNWxUVTM3V3dMMGVicUdXcG8xZ0cxZlVtclNGUXlEb3Z2bzlWLVdNSUtGZHF3d0lTcUtHbXF3bXlxdEpwNW94Y294cW8yZnJhVUtMZTMtSXZRckZqb2NHU0VkWXBDMVQyUnRJQQ?oc=5","Wed, 30 Sep 2026 10:08:02 GMT","DBV Technologies Submits FDA Biologics License Application for VIASKIN Peanut Patch in Children Ages 4-7 Kalkine Media",{"title":217,"link":218,"pubDate":219,"description":220,"source":221},"Citizens reiterates DBV Technologies stock rating on BLA milestone By Investing.com - Investing.com South Africa","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxNZGpnUGYtTzBNdW9fQ0JzSXZVS1Z6c21ubENXeWhDdnpMakxVaXBTanFabWNJWW8wY1hUbnp1VGg0VjFndy1OQnlBaURlOGZnTTZpVGtpVFVOeFlocjl0OWpSU21rWXE5WTVfaDRnbUpaLUVuSVZLUElCdnExZGtQaDZGNTJhZHJzQnpZUU00WjRuVWpRUlV3bkR5UDdMSlh4UmRlaUQtb0x0VlIzRXd1cEpkYk1VWjBGaGU2Y0twN0xEZ1VVQmc?oc=5","Wed, 30 Sep 2026 09:33:50 GMT","Citizens reiterates DBV Technologies stock rating on BLA milestone By Investing.com Investing.com South Africa","Investing.com South Africa"]